ACADIA PHARMACEUTICALS INC Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Acadia Pharmaceuticals Inc Operating Lease, Payments for the quarter ending September 30, 2024 was $2.67M, a 14% increase year-over-year.
  • Acadia Pharmaceuticals Inc Operating Lease, Payments for the twelve months ending September 30, 2024 was $10.1M, a 8.22% increase year-over-year.
  • Acadia Pharmaceuticals Inc annual Operating Lease, Payments for 2023 was $9.46M, a 4.11% increase from 2022.
  • Acadia Pharmaceuticals Inc annual Operating Lease, Payments for 2022 was $9.08M, a 71.3% increase from 2021.
  • Acadia Pharmaceuticals Inc annual Operating Lease, Payments for 2021 was $5.3M, a 18.4% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $9.46M +$373K +4.11% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $9.08M +$3.78M +71.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $5.3M +$823K +18.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $4.48M -$361K -7.46% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $4.84M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.